UroGen Pharma URGN Current ratio

Current ratio at other companies

Bristol-Myers SquibbBMY

1.5×+0.3×

PfizerPFE

1.2×0.0×

Johnson & JohnsonJNJ

1.1×+0.1×

Merck & Co.MRK

1.3×-0.1×

ImmunityBio, Inc.IBRX

6.7×+4.4×

Aura Biosciences, Inc.AURA

7.1×-4.0×

FAQ

What is UroGen Pharma's current ratio?

UroGen Pharma (URGN) reported current ratio of 3.8× in Q2 2026.

How has UroGen Pharma's current ratio changed year-over-year?

UroGen Pharma's current ratio decreased by 8.2% year-over-year, from 4.1× to 3.8×.

What is the long-term trend for UroGen Pharma's current ratio?

Over 5 years (2020 to 2025), UroGen Pharma's current ratio has grown at a -5.8% compound annual growth rate (CAGR), from 5.4× to 4×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.